These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6392599)

  • 21. [Urinary tract infections due to Serratia marcescens. I. Antimicrobial susceptibility patterns of clinical isolates of Serratia marcescens (author's transl)].
    Igari J; Kosakai N
    Jpn J Antibiot; 1977 Oct; 30(10):840-6. PubMed ID: 338940
    [No Abstract]   [Full Text] [Related]  

  • 22. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1985). III. Secular changes in susceptibility].
    Kosakai N; Kumamoto Y; Sakai S; Hirose T; Okayama S; Shigeta S; Shiraiwa Y; Yoshida H; Miura Y; Ogata M
    Jpn J Antibiot; 1987 Dec; 40(12):2026-142. PubMed ID: 3448256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of chlorhexidine gluconate on Serratia marcescens clinical isolates: relevance to serotype O3].
    Marumo K; Nakamura Y
    Rinsho Byori; 1994 Jul; 42(7):731-6. PubMed ID: 8065040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [O-serotypes, biochemical properties and antimicrobial susceptibility of Serratia marcescens isolates from clinical specimens].
    Marumo K; Aoki Y; Takeuchi T
    Rinsho Byori; 1987 May; 35(5):555-60. PubMed ID: 2441093
    [No Abstract]   [Full Text] [Related]  

  • 25. [Epidemiological evaluation of Serratia marcescens clinical isolates in a general hospital during the past three years: appearance of O-antigens O2 and O14].
    Marumo K; Nakamura Y; Sakurai C
    Rinsho Byori; 1998 Jul; 46(7):728-33. PubMed ID: 9721543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific distribution of R factors in Serratia marcescens strains isolated from hospital infections.
    Schaefler S; Winter J; Catelli A; Greene J; Toharski B
    Appl Microbiol; 1971 Sep; 22(3):339-43. PubMed ID: 4940874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In-vitro susceptibility of clinical isolates of Serratia species to antimicrobial agents.
    Sofianou D; Proya E; Kondodimou A
    J Chemother; 1990 Apr; 2(2):79-81. PubMed ID: 2362189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nalidixic acid susceptibility testing of clinical isolates of Serratia marcescens.
    Jollick JD; Schervish-Swierkosz EM; Brown WJ
    Antimicrob Agents Chemother; 1973 Nov; 4(5):532-7. PubMed ID: 4598848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multicenter surveillance of antimicrobial resistance in Serratia marcescens in Taiwan.
    Liou BH; Duh RW; Lin YT; Lauderdale TL; Fung CP;
    J Microbiol Immunol Infect; 2014 Oct; 47(5):387-93. PubMed ID: 23751769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A laboratory assessment of the activities of four aminoglycosides.
    Schrire L; Robinson RG; Koornhof HJ
    S Afr Med J; 1984 Jun; 65(23):922-4. PubMed ID: 6427946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1984). III. Secular changes in susceptibility].
    Kosakai N; Kumamoto Y; Sakai S; Hirose T; Shigeta S; Shiraiwa Y; Miura Y; Ogata M; Tazaki H; Iri H
    Jpn J Antibiot; 1986 Nov; 39(11):3019-93. PubMed ID: 3102809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endemic Serratia marcescens in the Veterans Administration Hospital in Pittsburgh, Pa., 1971--1976.
    Brown A; Davis L; Yee RB; Postic B
    Health Lab Sci; 1978 Jul; 15(3):159-67. PubMed ID: 359506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Sensitivity of Serratia marcescens to chemotherapy].
    Neguţ M; Niţulescu A; Potcoavă R
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1978; 23(1):27-36. PubMed ID: 349661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outbreak of nosocomial urinary tract infections caused by Serratia marcescens.
    Okuda T; Endo N; Osada Y; Zen-Yoji H
    J Clin Microbiol; 1984 Oct; 20(4):691-5. PubMed ID: 6386875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of The Pathogenic Potential of Insecticidal
    Konecka E; Mokracka J; Krzymińska S; Kaznowski A
    Pol J Microbiol; 2019; 68(2):185-191. PubMed ID: 31257791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1992)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N
    Jpn J Antibiot; 1996 Jan; 49(1):34-70. PubMed ID: 8851305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of subinhibitory levels of aminoglycosides and fluoroquinolines on hydrophobicity and motility of Serratia marcescens].
    Majtán V; Majtánová L
    Epidemiol Mikrobiol Imunol; 2001 Feb; 50(1):26-30. PubMed ID: 11233670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural antibiotic susceptibility of strains of Serratia marcescens and the S. liquefaciens complex: S. liquefaciens sensu stricto, S. proteamaculans and S. grimesii.
    Stock I; Grueger T; Wiedemann B
    Int J Antimicrob Agents; 2003 Jul; 22(1):35-47. PubMed ID: 12842326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1994). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Kitagawa R; Igari J; Oguri T; Kosakai N; Yamaguchi K; Kashitani F; Yonezu S; Yamanaka Y; Takaha M; Iori F
    Jpn J Antibiot; 1996 May; 49(5):465-93. PubMed ID: 8752862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aminoglycoside resistance patterns of Serratia marcescens strains of clinical origin.
    Coria-Jiménez R; Ortiz-Torres C
    Epidemiol Infect; 1994 Feb; 112(1):125-31. PubMed ID: 8119351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.